Wang; Xunqiang

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wang; Xunqiang.The latest application filed is for "quinoline compound or pharmaceutically acceptable salt thereof for treating ewing's sarcoma".

Company Profile

11.8.14

Wang; Xunqiang - Jiangsu CN
WANG; Xunqiang - Lianyungang CN
Wang; Xunqiang - Jaingsu CN
WANG; Xunqiang - Lianyungang City CN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Quinoline derivative for treatment of nasopharyngeal carcinoma Grant 11,419,862 - Wang , et al. August 23, 2	2022-08-23
Quinoline Compound Or Pharmaceutically Acceptable Salt Thereof For Treating Ewing's Sarcoma App 20220193067 - ZHAN; Xiaole ; et al.	2022-06-23
Combined Pharmaceutical Composition For Treating Small Cell Lung Cancer App 20220175759 - WANG; Shanchun ; et al.	2022-06-09
Combined Pharmaceutical Composition For Treating Tumor App 20220089742 - ZHANG; Xiquan ; et al.	2022-03-24
Quinoline Derivative Used For Treating Small Cell Lung Cancer App 20220031689 - WANG; Shanchun ; et al.	2022-02-03
Quinoline derivatives for non-small cell lung cancer Grant 10,888,559 - Wang , et al. January 12, 2	2021-01-12
Quinoline Derivative For Treatment Of Triple-negative Breast Cancer App 20200405709 - TIAN; Xin ; et al.	2020-12-31
Quinoline Derivative For Treatment Of Nasopharyngeal Carcinoma App 20200352932 - WANG; Shanchun ; et al.	2020-11-12
Application Of Novel Tyrosine Kinase Inhibitor, Anlotinib, In Osteosarcoma And Chondrosarcoma App 20200316053 - HUA; Yingqi ; et al.	2020-10-08
Quinoline derivative for treating gastric cancer Grant 10,736,887 - Chen , et al. A	2020-08-11
Use of quinoline derivatives for treating oesophageal cancer and treatment method, pharmaceutical composition and kit thereof Grant 10,561,647 - Wang , et al. Feb	2020-02-18
Quinoline Derivatives For Non - Small Cell Lung Cancer App 20190298712 - Wang; Xunqiang ; et al.	2019-10-03
Method For Treating Tumour, Pharmaceutical Composition And Medicinal Kit App 20190269671 - Wang; Shanchun ; et al.	2019-09-05
Quinoline derivative against non-small cell lung cancer Grant 10,307,412 - Wang , et al.	2019-06-04
Quinoline Derivative For Treating Gastric Cancer App 20190125739 - Chen; Jie ; et al.	2019-05-02
Method for treating tumour, pharmaceutical composition and medicinal kit Grant 10,251,876 - Wang , et al.	2019-04-09
Use Of Quinoline Derivatives For Treating Oesophageal Cancer And Treatment Method, Pharmaceutical Composition And Kit Thereof App 20190022082 - WANG; Xunqiang ; et al.	2019-01-24
Methods and uses of quinoline derivatives in the treatment of soft tissue sarcomas and pharmaceutical compositions for treatment of same Grant 10,183,017 - Zhang , et al. Ja	2019-01-22
Methods And Uses Of Quinoline Derivatives In The Treatment Of Soft Tissue Sarcomas And Pharmaceutical Compositions For Treatment Of Same App 20180235953 - Zhang; Xiquan ; et al.	2018-08-23
Methods and uses of quinoline derivatives in the treatment of soft tissue sarcomas and pharmaceutical compositions for treatment of same Grant 9,968,597 - Zhang , et al. May 15, 2	2018-05-15
Quinoline Derivative Against Non-small Cell Lung Cancer App 20170304290 - Wang; Xunqiang ; et al.	2017-10-26
Methods And Uses Of Quinoline Derivatives In The Treatment Of Soft Tissue Sarcomas And Pharmaceutical Compositions For Treatment Of Same App 20170202828 - Zhang; Xiquan ; et al.	2017-07-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.